Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Carlos, López de Silanes"'
Publikováno v:
Revista Discapacidad, Clínica, Neurociencias, Vol 7, Iss 1, Pp 27-39 (2020)
La esclerosis múltiple (EM) es una enfermedad crónica y neurodegenerativa del Sistema Nervioso Central con clara prevalencia de alteraciones cognitivas, especialmente atención, memoria y funciones ejecutivas. Los estudios de volumetría han mostra
Externí odkaz:
https://doaj.org/article/e7b9b8c25a354fa9b3cb64f9e5821fab
Autor:
Inmaculada Toboso, Amalia Tejeda-Velarde, Roberto Alvarez-Lafuente, Rafael Arroyo, Harald Hegen, Florian Deisenhammer, Susana Sainz de la Maza, José C. Alvarez-Cermeño, Guillermo Izquierdo, Dolores Paramo, Pedro Oliva, Bonaventura Casanova, Eduardo Agüera-Morales, Diego Franciotta, Matteo Gastaldi, Oscar Fernández, Patricia Urbaneja, José M. Garcia-Dominguez, Fernando Romero, Alicia Laroni, Antonio Uccelli, Angel Perez-Sempere, Albert Saiz, Yolanda Blanco, Daniela Galimberti, Elio Scarpini, Carmen Espejo, Xavier Montalban, Ludwig Rasche, Friedemann Paul, Inés González, Elena Álvarez, Cristina Ramo, Ana B. Caminero, Yolanda Aladro, Carmen Calles, Pablo Eguía, Antonio Belenguer-Benavides, Lluis Ramió-Torrentà, Ester Quintana, José E. Martínez-Rodríguez, Agustín Oterino, Carlos López de Silanes, Luis I. Casanova, Lamberto Landete, Jette Frederiksen, Gabriel Bsteh, Patricia Mulero, Manuel Comabella, Miguel A. Hernández, Mercedes Espiño, José M. Prieto, Domingo Pérez, María Otano, Francisco Padilla, Juan A. García-Merino, Laura Navarro, Alfonso Muriel, Lucienne Costa Frossard, Luisa M. Villar
Publikováno v:
Frontiers in Neurology, Vol 11 (2020)
Overview: We assessed the role of age and disease activity as new factors contributing to establish the risk of progressive multifocal leucoencephalopathy in multiple sclerosis patients treated with natalizumab in 36 University Hospitals in Europe. W
Externí odkaz:
https://doaj.org/article/c82f6fa684d240fe86a6b469a1788aa1
Autor:
Adela González-Jiménez, Pilar López-Cotarelo, Teresa Agudo-Jiménez, Ignacio Casanova, Carlos López de Silanes, Ángeles Martín-Requero, Fuencisla Matesanz, Elena Urcelay, Laura Espino-Paisán
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 15; Pages: 8116
13 p.-4 fig.-1 tab.
Deficiencies in Mannosidase β (MANBA) are associated with neurological abnormalities and recurrent infections. The single nucleotide polymorphism located in the 3′UTR of MANBA, rs7665090, was found to be associated with mu
Deficiencies in Mannosidase β (MANBA) are associated with neurological abnormalities and recurrent infections. The single nucleotide polymorphism located in the 3′UTR of MANBA, rs7665090, was found to be associated with mu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f91b3a3a439dd8db2c2f006f41173084
http://hdl.handle.net/10261/296299
http://hdl.handle.net/10261/296299
Autor:
Susana Sainz de la Maza, Israel Thuissard, Andy Castro, Lucienne Costa-Frossard, Carmen Muñoz, Carlos López de Silanes, Julia Sabin, Hugo Martín, Yolanda Aladro, Ignacio Casanova, Irene Moreno, M Luisa Martínez-Ginés, Mayra Gómez-Moreno, Victoria Galan, Sarai Urtiaga, Lucía Ayuso, Elena Rodríguez-García, Celia Oreja-Guevara, Belen Pilo, Pedro Sánchez, Virginia Meca-Lallana, J.A. García-Merino, Laura Borrega, Alberto Lozano, Judit Díaz-Díaz
Publikováno v:
Journal of Neurology. 267:2362-2371
Dimethyl fumarate (DMF) tolerability and safety in multiple sclerosis (MS) has been analyzed in randomized clinical trials. Real-life studies are needed to assess possible harms of this therapy in a wider MS population. To evaluate DMF tolerability,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1fe69e36e011ba058e80fab4196ca64f
https://doi.org/10.1007/s00415-020-09848-7
https://doi.org/10.1007/s00415-020-09848-7
Autor:
Elena Rodríguez García, Clara Aguirre, Julia Sabín Muñoz, Mayra Gómez Moreno, Aida Orviz García, Virginia Meca Lallana, Juan Pablo Cuello, Susana Sainz de la Maza, Luisa María Villar-Guimerans, Laura Borrega Canelo, Mercedes Espiño, Guillermo Fernández-Dono, Lucienne Costa-Frossard, María Luisa Martínez Ginés, Alba Cárcamo, Carlos López de Silanes de Miguel, Francisco Valenzuela Rojas, Irene Moreno-Torres, Rosario Blasco, Carmen Santiuste, Ignacio Casanova, Fernando Pérez Parra, Victor Elvira, Elda Maria Alba Suarez, José Manuel García Domínguez, Celia Oreja-Guevara, Enric Monreal, Yolanda Aladro
Publikováno v:
Moreno-Torres, I, Lallana, V M, Costa-Frossard, L, Oreja-Guevara, C, Aguirre, C, Suárez, E M A, Moreno, M G, Canelo, L B, Muñoz, J S, Aladro, Y, Cárcamo, A, García, E R, Cuello, J P, Monreal, E, Sainz de la Maza, S, Pérez Parra, F P P, Valenzuela Rojas, F, López de Silanes de Miguel, C, Casanova, I, Martínez Gines, M L, Blasco, R, García, A O, Villar-Guimerans, L M, Fernández-Dono, G, Elvira, V, Santiuste, C, Espiño, M & García Domínguez, J M 2021, ' Risk and outcomes of COVID-19 in patients with multiple sclerosis ', European Journal of Neurology, vol. 28, no. 11, pp. 3712-3721 . https://doi.org/10.1111/ene.14990
European Journal of Neurology
European Journal of Neurology
Background and purpose Limited information is available on incidence and outcomes of COVID‐19 in patients with multiple sclerosis (MS). This study investigated the risks of SARS‐CoV‐2 infection and COVID‐19‐related outcomes in patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ae7299d6f820bb39d813d496929552e
https://hdl.handle.net/20.500.11820/5c78a1b6-11af-46d2-b885-58869838c58a
https://hdl.handle.net/20.500.11820/5c78a1b6-11af-46d2-b885-58869838c58a
Autor:
Ignacio Casanova, Alejandro Prada, Carlos López De Silanes, Luis Gonzaga, Laura Barrio, Miriam Eimil, Beatriz Oyanguren, Pilar Alcántara, Miguel Ángel Saíz, Blanca Díaz, Miriam González, Marta González
Publikováno v:
Current rheumatology reviews.
Abstract: Systemic inflammatory diseases could produce neurologic complications, and they are frequently incorporated in the differential diagnosis of neurological symptoms. There are wellestablished criteria to meet the diagnosis of neurologic manif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c27b42c395c074ea0f9796c4c3d895db
https://pubmed.ncbi.nlm.nih.gov/35593339
https://pubmed.ncbi.nlm.nih.gov/35593339
Autor:
Carmen Bravo-Llatas, Susana Muñoz-Lasa, Nuria Máximo-Bocanegra, Carlos López de Silanes, M. Ángeles Atín-Arratibel, Salvador Pastor-Jimeno
Publikováno v:
Medicina Clínica. 152:55-58
Resumen Introduccion y objetivo La hipoterapia se esta utilizando como un metodo muy prometedor en el tratamiento fisico de los pacientes con esclerosis multiple (EM). Material y metodo Se realizo un ensayo clinico abierto comparativo pre-post con in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d79e35deaa2651909c433ac44ccf16f2
https://doi.org/10.1016/j.medcli.2018.02.015
https://doi.org/10.1016/j.medcli.2018.02.015
Autor:
Javier Sotoca, Maria A. Terzaghi, Julia Gracia-Gil, Jorge Maurino, Gustavo Saposnik, Luis Brieva, Ana B. Caminero, Carlos López de Silanes, Angel P. Sempere
Publikováno v:
PATIENT-PATIENT CENTERED OUTCOMES RESEARCH
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname
Background Risk attitude is defined as the willingness to tolerate risk to achieve a greater expected return. Limited information is available on how relapsing-remitting multiple sclerosis people's perceptions about disease trajectory and risk attitu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7765733180bc939fd12165c35d93672f
https://link.springer.com/article/10.1007/s40271-020-00454-3
https://link.springer.com/article/10.1007/s40271-020-00454-3
Autor:
Belen, Pilo de la Fuente, Julia, Sabín, Victoria, Galán, Israel, Thuissard, Susana, Sainz de la Maza, Lucienne, Costa-Frossard, Mayra, Gómez-Moreno, Judit, Díaz-Díaz, Celia, Oreja-Guevara, Alberto, Lozano-Ros, José M, García-Domínguez, Laura, Borrego, Lucía, Ayuso, Andy, Castro, Pedro, Sánchez, Virginia, Meca-Lallana, Carmen, Muñoz, Ignacio, Casanova, Carlos, López de Silanes, Hugo, Martín, Elena, Rodríguez-García, Cristina, Andreu-Vázquez, Rosario, Blasco, Juan A, García-Merino, Yolanda, Aladro, Ricardo, Ginestal
Publikováno v:
CNS drugs. 34(12)
Dimethyl fumarate (DMF) has demonstrated efficacy in phase III studies. However, real-world data are still limited.The objective of this study was to describe the profile of patients who receive DMF and to assess the effectiveness of DMF regarding re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c83e6ff1b2366b2c57edf74618b69ff0
https://pubmed.ncbi.nlm.nih.gov/33226562
https://pubmed.ncbi.nlm.nih.gov/33226562
Autor:
Jorge, Maurino, Javier, Sotoca, Ángel P, Sempere, Luis, Brieva, Carlos, López de Silanes, Ana B, Caminero, María, Terzaghi, Julia, Gracia-Gil, Gustavo, Saposnik
Publikováno v:
The patient. 14(2)
Risk attitude is defined as the willingness to tolerate risk to achieve a greater expected return. Limited information is available on how relapsing-remitting multiple sclerosis people's perceptions about disease trajectory and risk attitude may infl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e9b8ba261c733f8b9d3410076e28b183
https://pubmed.ncbi.nlm.nih.gov/32975737
https://pubmed.ncbi.nlm.nih.gov/32975737